|
| (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid Basic information |
Product Name: | (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid | Synonyms: | (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid;(-)-N-[4-[[[(6S)-2-Amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxopteridin-6β-yl]methyl]amino]benzoyl]-L-glutamic acid;(6S)-Leucovorin;(S)-Leucovorin;N-[4-[[(2-Amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic Acid;Folinic Acid EP Impurity H;Folinic Acid Impurity H (Levofolinic Acid);Impurity H of Calcium Levofolinate | CAS: | 68538-85-2 | MF: | C20H23N7O7 | MW: | 473.44 | EINECS: | | Product Categories: | | Mol File: | 68538-85-2.mol | |
| (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid Chemical Properties |
density | 1.68±0.1 g/cm3(Predicted) | pka | 3.51±0.10(Predicted) |
| (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid Usage And Synthesis |
Definition | ChEBI: The pharmacologically active (6S)-stereoisomer of 5-formyltetrahydrofolic acid. |
| (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid Preparation Products And Raw materials |
|